Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
22.64
+0.04 (0.18%)
Apr 29, 2026, 4:08 PM HKT
22.38%
Market Cap 7.58B
Revenue (ttm) 1.18B
Net Income (ttm) 271.94M
Shares Out 335.58M
EPS (ttm) 0.84
PE Ratio 26.89
Forward PE 18.84
Dividend 0.25 (1.12%)
Ex-Dividend Date May 27, 2026
Volume 482,916
Average Volume 849,689
Open 22.52
Previous Close 22.60
Day's Range 22.44 - 22.86
52-Week Range 17.84 - 28.00
Beta 0.32
RSI 45.32
Earnings Date Mar 17, 2026

About HKG:2190

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. Its peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cover... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2012
Employees 925
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2190
Full Company Profile

Financial Performance

In 2025, HKG:2190's revenue was 1.06 billion, an increase of 35.15% compared to the previous year's 782.48 million. Earnings were 244.37 million, an increase of 143.75%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.